Stay updated with breaking news from Peterb Silverman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merus (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 22,386 shares of Merus stock in a transaction on Friday, December 15th. The stock was sold at an average price of $25.00, for a total transaction of $559,650.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available […]
Merus (NASDAQ:MRUS – Get Free Report)’s share price traded up 8.4% during trading on Tuesday . The company traded as high as $27.08 and last traded at $27.05. 371,198 shares traded hands during trading, an increase of 6% from the average session volume of 349,408 shares. The stock had previously closed at $24.95. Wall Street […]
- Zenocutuzumab (Zeno) in NRG1+ cancer potential registrational path and timeline update planned for first half of 2023 - Petosemtamab clinical and regulatory update planned for first half of 2023 -
- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive ("NRG1+") cancer have been treated with zenocutuzumab ("Zeno") monotherapy - Petosemtamab clinical update planned for first
- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive (“NRG1+”) cancer have been treated with zenocutuzumab (“Zeno”) monotherapy -...